Ganaxalone

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
158	結節性硬化症	1

158. 結節性硬化症

臨床試験数 : 112 / 薬物数 : 71 - (DrugBank : 19) / 標的遺伝子数 : 35 - 標的パスウェイ数 : 118

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05323734 (ClinicalTrials.gov)	April 1, 2022	21/3/2022	Adjunctive GNX Treatment Compared With Placebo in Children and Adults With TSC-related Epilepsy	A Phase 3, Double-blind, Randomized, Placebo-controlled Trial of Adjunctive Ganaxolone (GNX) Treatme ...	Tuberous Sclerosis Complex	Drug: Ganaxalone;Drug: Placebo	Marinus Pharmaceuticals	NULL	Recruiting	1 Year	65 Years	All	162	Phase 3	United States;Canada;France;Germany;Israel;Italy;Spain;United Kingdom

First Previous1Next Last